FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← NTLA · Intellia Therapeutics, Inc.
424B5The Raise

Intellia Therapeutics, Inc. files 424B5

Filed Feb 23, 2024 · 2y ago · Accession 0001193125-24-044711

Plain English

424B5 filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Intellia Therapeutics, Inc.
Ticker
NTLA
CIK
1652130
Form type
424B5
Filing date
Feb 23, 2024
Report date
—
Document
d783925d424b5.htm
Size
564 KB

More from NTLA

8-KReg FD Disclosure · Company UpdateJun 15, 20268-KShareholder VoteJun 10, 202610-QThe RecordMay 11, 20268-KResults of OperationsMay 11, 2026DEF 14AThe BallotApr 30, 2026DEFA14AThe BallotApr 30, 2026